MAPT and amyloidosis: Animal experiments have demonstrated that the upregulation of CYP1B1 is linked to the progression of tau pathology in the hTAU mouse model, which expresses six isoforms of human tau but is not associated with amyloid pathology progression in J20 mice [127].